livemint.com
94%
872
Covid vaccine: Canada changes AstraZeneca's Covishield label to add information about blood clots
Covishield vaccine to provide information on "very rare reports of blood clots associated with low levels of blood platelets."Covishield is Serum Institute of India's version of AZD1222, the vaccine developed by AstraZeneca in collaboration with the University of Oxford.Health Canada continues to back the Covid-19 vaccine, saying that it had not received any reports of these blood clots to date.Canada, which is using AstraZeneca doses made at the Serum Institute of India, has received 500,000 doses and expects to get 1.5 million more by May.It was received by its Canadian partner, Verity Pharmaceuticals, located in the Greater Toronto Area town of Mississauga.During a media interaction, Prime Minister Justin Trudeau had said, "Very early